SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123429
Filing Date
2024-11-07
Accepted
2024-11-07 16:31:02
Documents
62
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-20240930.htm   iXBRL 10-Q 1919439
2 EX-10.1 etnb-ex10_1.htm EX-10.1 48701
3 EX-10.2 etnb-ex10_2.htm EX-10.2 158520
4 EX-10.3 etnb-ex10_3.htm EX-10.3 1226332
5 EX-10.4 etnb-ex10_4.htm EX-10.4 175710
6 EX-31.1 etnb-ex31_1.htm EX-31.1 15158
7 EX-31.2 etnb-ex31_2.htm EX-31.2 15170
8 EX-32 etnb-ex32.htm EX-32 15369
9 GRAPHIC img164203169_0.jpg GRAPHIC 24775
  Complete submission text file 0000950170-24-123429.txt   9785844

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT etnb-20240930.xsd EX-101.SCH 1220987
64 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20240930_htm.xml XML 1302633
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 241436366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)